Medicure (MCUJF) Non-Current Debt (2009 - 2026)

Medicure (MCUJF) recorded quarterly Non-Current Debt of $62711.7 in Q1 2026, up 4.11% quarter-over-quarter from $60235.2 in Q4 2025.

Medicure (MCUJF) Non-Current Debt (2009 - 2026) Analysis & Trends

Medicure's Non-Current Debt history runs 13 years deep, the most recent figure standing at $62711.7 for Q1 2026.

In Q1 2026, Non-Current Debt changed N/A year-over-year to $62711.7; the TTM figure through Mar 2026 stood at $62711.7 (changed N/A YoY), while the FY2025 annual figure was $60235.2, changed N/A from the prior year.
Non-Current Debt was $62711.7 for Q1 2026 at Medicure, up from $60235.2 in the prior quarter.
In the past five years, Non-Current Debt ranged from a high of $62711.7 in Q1 2026 to a low of $59180.4 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	14.02 Bn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	9.05 Bn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	-
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	-
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	-
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	3.92 Bn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	1.48 Bn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	-
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	569.60 Mn
10	Medicure	-	-	2.57 Mn	62,711.69

Download Data